Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assunta Sartor

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Hospital discharge diagnoses in patients with positive blood cultures in an Italian academic hospitalFrancesca Valent, Laura Deroma, Roberto Cocconi, et al.
Journal of Global Antimicrobial Resistance|May 19, 2018
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, et al.
Therapeutic Drug Monitoring|February 11, 2020
Real-Time Therapeutic Drug Monitoring-Based Pharmacokinetic/Pharmacodynamic Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case StudyPier Giorgio Cojutti, Alessia Carnelutti, Silvia Mattelig, et al.
Journal of Global Antimicrobial Resistance|May 13, 2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactamNadia Castaldo, Filippo Givone, Maddalena Peghin, et al.
Diagnostic Microbiology and Infectious Disease|October 11, 2014
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast ItalyPiergiorgio Cojutti, Claudio Scarparo, Assunta Sartor, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniaePiergiorgio Cojutti, Assunta Sartor, Elda Righi, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2014
Current antibiotic management of prosthetic joint infections in Italy: the 'Udine strategy'Matteo Bassetti, Barbara Cadeo, Giovanni Villa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 21, 2019
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?Elda Righi, Alessia Carnelutti, Umberto Baccarani, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 8, 2024
Acute suppurative thyroiditis caused by Gemella Morbillorum: a case reportAlessandro Brunetti, Claudia Cipri, Assunta Sartor, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?Federico Pea, Paola Della Siega, Piergiorgio Cojutti, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Hospital discharge diagnoses in patients with positive blood cultures in an Italian academic hospitalFrancesca Valent, Laura Deroma, Roberto Cocconi, et al.
Journal of Global Antimicrobial Resistance|May 19, 2018
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, et al.
Therapeutic Drug Monitoring|February 11, 2020
Real-Time Therapeutic Drug Monitoring-Based Pharmacokinetic/Pharmacodynamic Optimization of Complex Antimicrobial Therapy in a Critically Ill Morbidly Obese Patient. Grand Round/A Case StudyPier Giorgio Cojutti, Alessia Carnelutti, Silvia Mattelig, et al.
Journal of Global Antimicrobial Resistance|May 13, 2017
Multidrug-resistant Pseudomonas aeruginosa skin and soft-tissue infection successfully treated with ceftolozane/tazobactamNadia Castaldo, Filippo Givone, Maddalena Peghin, et al.
Diagnostic Microbiology and Infectious Disease|October 11, 2014
A 5-year survey of antimicrobial susceptibility profiles of methicillin-resistant Staphylococcus aureus (MRSA) isolated from patients with bloodstream infections in Northeast ItalyPiergiorgio Cojutti, Claudio Scarparo, Assunta Sartor, et al.
Antimicrobial Agents and Chemotherapy|August 2, 2017
Population Pharmacokinetics of High-Dose Continuous-Infusion Meropenem and Considerations for Use in the Treatment of Infections Due to KPC-Producing Klebsiella pneumoniaePiergiorgio Cojutti, Assunta Sartor, Elda Righi, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2014
Current antibiotic management of prosthetic joint infections in Italy: the 'Udine strategy'Matteo Bassetti, Barbara Cadeo, Giovanni Villa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 21, 2019
Treatment of Candida infections with fluconazole in adult liver transplant recipients: Is TDM-guided dosing adaptation helpful?Elda Righi, Alessia Carnelutti, Umberto Baccarani, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|December 8, 2024
Acute suppurative thyroiditis caused by Gemella Morbillorum: a case reportAlessandro Brunetti, Claudia Cipri, Assunta Sartor, et al.
International Journal of Antimicrobial Agents|December 26, 2016
Might real-time pharmacokinetic/pharmacodynamic optimisation of high-dose continuous-infusion meropenem improve clinical cure in infections caused by KPC-producing Klebsiella pneumoniae?Federico Pea, Paola Della Siega, Piergiorgio Cojutti, et al.
Pageof 6